← Leaderboards
Susanne Bauman
Novan, Inc.
$592,972
Attributed
$592,972
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2011–12$500K$375K$250K$125K$0
'11
'12
Funding mix
By agency
NIH$592,972 · 1
By mechanism
R43$592,972 · 1
Top collaborators
No co-investigators on record.
Most similar at Novan, Inc.
Same institution · by research overlap
- Nathan Allan Stasko$5,350,703
- William R Kelce$148,105
Others in their field
Top investigators on “Antimicrobial”
- M Kariuki Njenga · Washington State University$56,426,595
- Henry F Chambers · Duke University$39,750,596
- Alon Singer · Helixbind, Inc.$37,820,504
- Vance G Fowler · Duke University$37,779,645
- Robert L Modlin · University Of California Los Angeles$35,877,010
- Marian Ewell · The Emmes Company, Llc$35,864,978
Research focus
AntimicrobialAntimicrobial DrugBacteriaBacterial ResistanceBactericideBactrobanBaseBeliefBreathingBreedingCell MembraneCessation Of LifeClinical ResearchContractsCostDiffuseDoseDrug DevelopmentDrug FormulationsDrug ResistanceFda ApprovedFightingFree RadicalsAccounting